EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Polyphenolic phytosomes for targeted drug delivery

I A Khabarov, S D Sergazy, A Amanzhan, A S Maikenova, A N Zhabayeva, S M Adekenov

Fitoterapia · 2025

DOI: 10.1016/j.fitote.2025.106920 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Fitoterapia, 2025. Verfasst von I A Khabarov und 5 weiteren Autor:innen. Beteiligte Einrichtung: JSC "Research and Production Center "Phytochemistry", 100019 Karaganda city, Republic of Kazakhstan. Hauptthemen laut MEDLINE: Polyphenols, Drug Delivery Systems, COVID-19 Drug Treatment. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Ministry of Education and Science of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, the attention of researchers is attracted by natural polyphenolic compounds, including flavonoids, which exhibit pronounced antioxidant, anti-inflammatory, and antitumor properties. More than 8500 phenolic compounds have been isolated and characterized from plant sources. Despite their therapeutic potential, clinical translation is limited by low water solubility, poor membrane permeability, and extensive first-pass metabolism, resulting in suboptimal bioavailability. This review provides a comprehensive analysis of phytosome technology, including the mechanism of complex formation, structural advantages compared to traditional nanocarriers, and its impact on pharmacokinetics and bioefficacy. Polyphenolic compounds, such as silybin, curcumin, quercetin, epigallocatechin gallate (EGCG), and grape seed proanthocyanidins, have been successfully formulated into phytosomes, resulting in a significant enhancement of oral bioavailability and therapeutic efficacy in both preclinical and clinical studies. It also highlights evidence from clinical trials involving phytosomal formulations in various disease contexts, including cancer, liver and metabolic disorders, neurodegeneration, and COVID-19. The safety profile of phytosomes is favorable, with most formulations well-tolerated even under long-term use. Current limitations, including formulation instability, lack of regulatory clarity, and challenges in industrial scale-up, are discussed alongside future directions in targeted delivery and combination therapies. Phytosomes represent a clinically viable platform that bridges natural product pharmacology with modern drug delivery technologies, offering a scalable and biocompatible strategy for improving the clinical impact of polyphenols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyphenolsDrug Delivery SystemsCOVID-19 Drug TreatmentHumansBiological AvailabilityAnimalsDrug CarriersCurcuminPhytosomes

Stichwörter der Autor:innen

BioavailabilityDrug delivery systemsPhytosomesPolyphenols

Substanzen

PolyphenolsDrug CarriersCurcuminPhytosomes

Autor:innen und Institutionen

  • JSC "Research and Production Center "Phytochemistry", 100019 Karaganda city, Republic of Kazakhstan.
  • JSC "Research and Production Center "Phytochemistry", 100019 Karaganda city, Republic of Kazakhstan. Electronic address: info@phyto.kz.

Förderung

  • Ministry of Education and Science of the Republic of Kazakhstan

Zitieren

APA

Khabarov, I. A., Sergazy, S. D., Amanzhan, A., Maikenova, A. S., Zhabayeva, A. N., & Adekenov, S. M. (2025). Polyphenolic phytosomes for targeted drug delivery. Fitoterapia. https://doi.org/10.1016/j.fitote.2025.106920

Vancouver

Khabarov IA, Sergazy SD, Amanzhan A, Maikenova AS, Zhabayeva AN, Adekenov SM. Polyphenolic phytosomes for targeted drug delivery. Fitoterapia. 2025. doi:10.1016/j.fitote.2025.106920

BibTeX
@article{Khabarov2025,
  author = {Khabarov, I A and Sergazy, S D and Amanzhan, A and Maikenova, A S and Zhabayeva, A N and Adekenov, S M},
  title = {Polyphenolic phytosomes for targeted drug delivery},
  journal = {Fitoterapia},
  year = {2025},
  doi = {10.1016/j.fitote.2025.106920}
}
Kostenlos starten →